Welcome to our dedicated page for Bbx Capital news (Ticker: BBXIA), a resource for investors and traders seeking the latest updates and insights on Bbx Capital stock.
BBX Capital (BBXIA) delivers strategic insights through its diversified portfolio spanning real estate development, vacation ownership via BlueGreen Corporation, and middle market investments. This news hub provides investors with essential updates on corporate milestones, financial disclosures, and operational developments.
Access authoritative coverage of BBXIA's earnings announcements, property acquisitions, and partnership initiatives. Our curated collection includes press releases on resort expansions, timeshare program enhancements, and strategic investments across financial services and retail sectors.
Key updates feature BlueGreen vacation club innovations, real estate portfolio growth, and management strategies for its operating businesses. Bookmark this page for direct access to BBX Capital's official communications and market-moving developments in one centralized location.
BBX Capital reported its financial results for the fourth quarter and year ended December 31, 2022. For Q4 2022, consolidated revenues increased to $107.6 million from $98.2 million in Q4 2021, and net income reached $15.4 million, up from $5.3 million. Yearly, total revenues rose to $342.0 million compared to $313.6 million, but net income fell to $28.0 million from $46.9 million. Diluted earnings per share (EPS) declined to $1.81 from $2.63. The company faces ongoing challenges, including inflation, rising interest rates, and decreased sales transactions anticipated in 2023.
BBX Capital, Inc. (OTCQX: BBXIA, PINK: BBXIB) announced its plans to release financial results for the fourth quarter and full year ended December 31, 2022. A press release detailing these results will be issued after market close on Wednesday, March 15, 2023. BBX Capital is a diversified holding company based in Florida, with principal holdings including BBX Capital Real Estate, BBX Sweet Holdings, and Renin.